Ontology highlight
ABSTRACT:
SUBMITTER: Doubrovina E
PROVIDER: S-EPMC3311278 | biostudies-literature | 2012 Mar
REPOSITORIES: biostudies-literature
Doubrovina Ekaterina E Oflaz-Sozmen Banu B Prockop Susan E SE Kernan Nancy A NA Abramson Sara S Teruya-Feldstein Julie J Hedvat Cyrus C Chou Joanne F JF Heller Glenn G Barker Juliet N JN Boulad Farid F Castro-Malaspina Hugo H George Diane D Jakubowski Ann A Koehne Guenther G Papadopoulos Esperanza B EB Scaradavou Andromachi A Small Trudy N TN Khalaf Ramzi R Young James W JW O'Reilly Richard J RJ
Blood 20111202 11
We evaluated HLA-compatible donor leukocyte infusions (DLIs) and HLA-compatible or HLA-disparate EBV-specific T cells (EBV-CTLs) in 49 hematopoietic cell transplantation recipients with biopsy-proven EBV-lymphoproliferative disease (EBV-LPD). DLIs and EBV-CTLs each induced durable complete or partial remissions in 73% and 68% of treated patients including 74% and 72% of patients surviving ≥ 8 days after infusion, respectively. Reversible acute GVHD occurred in recipients of DLIs (17%) but not EB ...[more]